Dr. Ian Thompson, Jr.

Dr. Michael Liss

Dr. Dan Lin
Principal Investigators
Dr. Ian Thompson, Jr.
Dr. Thompson received his undergraduate degree from West Point and his M.D. degree from Tulane University. After a residency in Urology in San Antonio, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Thompson has published almost 700 scientific papers and previously served on the Cancer Centers Parent Committee (Committee A) of the National Cancer Institute, President of the Society of Urology Oncology, President of the American Board of Urology, and Chair of the Residency Review Committee. He currently serves as Chair of the Genitourinary Committee of the Southwest Oncology Group and is a member of the Board of Scientific Advisors of the National Cancer Institute. He has been continuously funded by the National Cancer Institute since 2000.
Dr. Michael Liss
Dr. Liss received his medical degree from the Medical School of Wisconsin and his residency training at the University of California at San Diego. He completed a fellowship in Urologic Oncology at the University of California at San Diego and a Masters of Applied Science in Clinical Trials. Dr. Liss currently serves as the medical director of the clinical research at the University Hospital and is Assistant Professor of Urology at the University of Texas Health Science Center at San Antonio.
Dr. Daniel Lin
Dr. Lin received his medical degree from Vanderbilt University Medical Center and his residency training at the University of Washington. He completed a fellowship in Urologic Oncology at the Memorial Sloan-Kettering Cancer Center. Dr. Lin is the Chief of Urologic Oncology at the University of Washington's Department of Urology and a urologist specializing in genitourinary oncologic surgery. His clinical and research interests include genitourinary oncology, early detection and prevention and basic research. He is Principal Investigator of the Canary Prostate Active Surveillance Study and is the Organ Site Chair of Prostate Cancer for the Southwest Oncology Group.